IDEXX Laboratories executive chair Jonathan Jay Mazelsky reports sale of $17.68 million in common shares
IDXX•IDEXX Laboratories Executive Chair Jonathan Jay Mazelsky sold 25,140 common shares on November 4, 2026, at prices ranging from $698.2625 to $711.9475 per share. He also exercised options for 25,140 shares at $178.26 each and held 83,803 shares directly afterward.
1. Share transactions
Mazelsky sold 25,140 IDEXX Laboratories common shares on November 4, 2026, with reported sale prices ranging from $698.2625 to $711.9475 per share. He also exercised non-qualified stock options for 25,140 common shares at $178.26 per share.
2. Direct holdings
Following the transactions, Mazelsky’s direct common stock holdings totaled 83,803 shares.
